Consider the Cycler

Earlier this summer scientists from New England Biolabs in Beverly, Mass., announced they had discovered a new way to copy DNA. Their method, called helicase-dependent amplification (HDA), reportedly mimics in vivo DNA replication better than PCR does.1 Moreover, HDA can be conducted at a single temperature, thus obviating the need for thermocycling. In the future, perhaps the limitations of PCR – that it is reagent intensive, requires expensive equipment, is difficult to reproduce, and ge

Written byLeslie Pray
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Earlier this summer scientists from New England Biolabs in Beverly, Mass., announced they had discovered a new way to copy DNA. Their method, called helicase-dependent amplification (HDA), reportedly mimics in vivo DNA replication better than PCR does.1 Moreover, HDA can be conducted at a single temperature, thus obviating the need for thermocycling. In the future, perhaps the limitations of PCR – that it is reagent intensive, requires expensive equipment, is difficult to reproduce, and generally is not linear – will be surmounted by new technologies, HDA or otherwise.

In the beginning, there was Taq. Now there are thermostable enzymes, and lots of them. First isolated from the heatloving Thermus aquaticus, Taq DNA polymerase was, for many years, the enzyme for PCR. Taq may still be the industry standard, but its error rate – nearly 1 × 10-4 to 2 × 10-5 mistakes per base pair – is high compared to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies